Search Results - "Leirvaag, B."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Olaparib monotherapy as primary treatment in unselected triple negative breast cancer by Eikesdal, H.P., Yndestad, S., Elzawahry, A., Llop-Guevara, A., Gilje, B., Blix, E.S., Espelid, H., Lundgren, S., Geisler, J., Vagstad, G., Venizelos, A., Minsaas, L., Leirvaag, B., Gudlaugsson, E.G., Vintermyr, O.K., Aase, H.S., Aas, T., Balmaña, J., Serra, V., Janssen, E.A.M., Knappskog, S., Lønning, P.E.

    Published in Annals of oncology (01-02-2021)
    “…The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi…”
    Get full text
    Journal Article
  2. 2

    Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer by HELLE, S. I, GEISLER, J, ANKER, G. B, LEIRVAAG, B, HOLLY, J. M. P, LONNING, P. E

    Published in British journal of cancer (20-07-2001)
    “…Alterations in the insulin-like growth factor (IGF)-system were evaluated in 16 patients treated with diethylstilboestrol 5 mg 3 times daily. Fasting blood…”
    Get full text
    Journal Article
  3. 3

    Abstract P4-01-02: Low ATM Expression Levels Predict Resistance to Anthracyclins in TP53 and CHK2 Wild-Type Breast Tumors by Knappskog, S, Chrisanthar, R, Løkkevik, E, Anker, G, østenstad, B, Lundgren, S, Risberg, T, Mjaaland, I, Staalesen, V, Miletic, H, Leirvaag, B, Lillehaug, JR, Lønning, PE

    Published in Cancer research (Chicago, Ill.) (15-12-2010)
    “…Background: Mutations in TP53 and its upstream p53-activator Chk2, are known to be associated with resistance to anthracycline and mitomycin treatment in…”
    Get full text
    Journal Article
  4. 4

    Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer by STAALESEN, Vidar, LEIRVAAG, Beryl, LILLEHAUG, Johan Richard, LØNNING, Per Eystein

    Published in Clinical cancer research (15-05-2004)
    “…Purpose: The cyclin-dependent kinase inhibitor p21 acts as a main executor of p53-induced growth arrest. Recently, a second transcript, p21B , was found to…”
    Get full text
    Journal Article
  5. 5

    Comparison of the centrifugal and roller pump in elective coronary artery bypass surgery--a prospective, randomized study with special emphasis upon platelet activation by Andersen, Knut S, Nygreen, Else L, Grong, Ketil, Leirvaag, Beryl, Holmsen, Holm

    “…Objective--Evaluation of the centrifugal pump vs roller pump concerning effects upon platelet function, hemolysis and clinical outcome in elective coronary…”
    Get more information
    Journal Article
  6. 6